3v9v: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
[[Image:3v9v.jpg|left|200px]]
[[Image:3v9v.png|left|200px]]


<!--
The line below this paragraph, containing "STRUCTURE_3v9v", creates the "Structure Box" on the page.
You may change the PDB parameter (which sets the PDB file loaded into the applet)
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
or leave the SCENE parameter empty for the default display.
-->
{{STRUCTURE_3v9v|  PDB=3v9v  |  SCENE=  }}  
{{STRUCTURE_3v9v|  PDB=3v9v  |  SCENE=  }}  


===Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator===
===Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator===


<!--
The line below this paragraph, {{ABSTRACT_PUBMED_22225641}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 22225641 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_22225641}}
{{ABSTRACT_PUBMED_22225641}}



Revision as of 13:21, 8 August 2012

File:3v9v.png

Template:STRUCTURE 3v9v

Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulatorCrystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator

Template:ABSTRACT PUBMED 22225641

About this StructureAbout this Structure

3v9v is a 2 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.

ReferenceReference

[xtra 1]

  1. Furukawa A, Arita T, Fukuzaki T, Satoh S, Mori M, Honda T, Matsui Y, Wakabayashi K, Hayashi S, Araki K, Ohsumi J. Substituents at the naphthalene C3 position of (-)-Cercosporamide derivatives significantly affect the maximal efficacy as PPARgamma partial agonists. Bioorg Med Chem Lett. 2012 Feb 1;22(3):1348-51. Epub 2011 Dec 16. PMID:22225641 doi:10.1016/j.bmcl.2011.12.066

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA